Susan Akers-Smith has been appointed vice president of Early Phase Oncology Development at INC Research. Ms. Akers-Smith will provide global leadership for advanced clinical development solutions to meet the early phase needs of the company’s oncology customers, with the goal of driving growth in this key area of the business.
Ms. Akers-Smith has served in various management and operational positions at INC Research in the oncology therapeutic business unit, and managed complex early phase oncology trials. She has more than a decade of management experience in the CRO industry focused on early-phase oncology development, with therapeutic experience including a broad range of study designs and tumor types.
“We are thrilled to recognize Susan’s individual efforts, creativity and performance through this well-deserved promotion,” said Nicholas Kenny, Ph.D., executive vice president and general manager, Global Oncology and Hematology, INC Research. “We always strive to combine operational efficiency with the latest advancements in medical and regulatory knowledge to conduct cancer trials of the highest quality. Susan epitomizes the leadership traits necessary for this role and we look forward to leveraging her experience to further support the growing early phase oncology research needs of our customers.”